Pyridostigmine

Pyridostigmine

SCHEMBL4431136

CN(C)C(=O)Oc1ccc[n+](C)c1.O=S=O

nearest known ligand 0.94

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHE

The experimentally established mechanism targets of Pyridostigmine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ACHE known ✓ P22303 12/20 0.94
BCHE P06276 6/20 0.94
LMNA P02545 4/20 0.94
GLA P06280 2/20 0.94
TSHR P16473 1/20 0.94
MAPK1 P28482 1/20 0.94
RAB9A P51151 1/20 0.52
KMT2A Q03164 2/20 0.44
NPSR1 Q6W5P4 2/20 0.44
MEN1 O00255 1/20 0.44
ALDH1A1 P00352 1/20 0.44
PKM P14618 1/20 0.44
NNMT P40261 1/20 0.41
USP2 O75604 1/20 0.41
GAA P10253 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pyridostigmine SCHEMBL1317 0.97 ACHE (1.00) ACHEBCHELMNAGLATSHR
Pyridostigmine SCHEMBL29356532 0.97 ACHE (1.00) ACHEBCHELMNAGLATSHR
Pyridostigmine SCHEMBL29353353 0.95 ACHE (1.00) ACHEBCHELMNAGLATSHR
Pyridostigmine SCHEMBL2761401 0.95 ACHE (0.97) ACHEBCHELMNAGLATSHR
Pyridostigmine SCHEMBL5791280 0.95 ACHE (0.97) ACHEBCHELMNAGLATSHR
Pyridostigmine SCHEMBL41147 0.95 ACHE (1.00) ACHEBCHELMNAGLATSHR
Pyridostigmine SCHEMBL6536137 0.95 ACHE (0.97) ACHEBCHELMNAGLATSHR
Pyridostigmine SCHEMBL27511002 0.94 ACHE (0.94) ACHEBCHELMNAGLATSHR
Pyridostigmine SCHEMBL4301247 0.94 ACHE (0.97) ACHEBCHELMNAGLATSHR
Pyridostigmine SCHEMBL19971970 0.89 ACHE (0.85) ACHEBCHELMNAGLATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090264401-A1 SUBSTITUTED PYRIMIDIN-5-CARBOXAMIDES 281 ASTRAZENECA AB (SE) 2009-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090264401-A1 SUBSTITUTED PYRIMIDIN-5-CARBOXAMIDES 281 CYP2S1, HSD11B1, HSD3B1 ACHE 3645/4885BCHE 1411/4885LMNA 4185/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.